Derhy Sarah, Gaillot Julie, Rousseau Sophie, Piel Clément, Thorrington Dominic, Zanetti Laura, Gall Bérengère, Venot Cyprien, Chyderiotis Sandra, Mueller Judith
Institut national du cancer, département prévention, 52, avenue André-Morizet, 92100 Boulogne-Billancourt, France.
Institut national du cancer, département prévention, 52, avenue André-Morizet, 92100 Boulogne-Billancourt, France.
Bull Cancer. 2022 Apr;109(4):445-456. doi: 10.1016/j.bulcan.2022.01.005. Epub 2022 Feb 12.
As part of an analysis on the extension of the HPV vaccination to French boys, the French National Cancer Institute (INCa) and the French National Authority for Health (HAS) have conducted in collaboration a survey on HPV vaccine acceptance in July 2019. This survey was completed by parents of children aged 11-19 and general practitioners (GPs). Questions focused on their representations, practices and intentions in the context of the future policy change allowing boys to get vaccinated against HPV.
The survey was conducted between June 20 and July 12, 2019. It focused on two populations: a nationally representative sample of parents with at least one girl aged 11-19 and/or one boy aged 11-14 (n=1984) and a representative sample of GPs in mainland France. Data were collected through a web-based questionnaire with a mean completion time of 10minutes for parents and GPs. The quota method was applied to ensure the representative nature of the samples based on (i) gender, age, children (girl aged 11-14 and/or boy aged 11-14) of the household, socio-professional category of the "head of the household", size of urban area and region for the parents' sample and based on (ii) gender, age, region and type of practice for the GPs' sample.
Although most GPs were very favourable towards HPV vaccination (94%), they considered it one of the most challenging vaccinations to get parents to adhere to (82%). A notable percentage of parents have unfavourable opinions towards HPV vaccination (25%). The three main barriers cited by parents of non-vaccinated girls were: the fear of adverse effects, the lack of information, and the fact that the GP did not propose it. Regarding the extension of HPV vaccination to boys, 84 % of GPs would recommend this vaccination to boys if it was included in the vaccination schedule, and 88 % of those who did not routinely recommend HPV vaccination to girls would be more likely to offer it to girls if the extension was recommended.
作为对法国男孩人乳头瘤病毒（HPV）疫苗接种推广情况分析的一部分，法国国家癌症研究所（INCa）和法国国家卫生管理局（HAS）于2019年7月联合开展了一项关于HPV疫苗接受度的调查。此次调查由11至19岁儿童的家长和全科医生（GPs）完成。问题聚焦于在未来允许男孩接种HPV疫苗的政策变化背景下，他们的认知、做法和意愿。
该调查于2019年6月20日至7月12日进行。调查聚焦于两类人群：一类是全国范围内具有代表性的样本，包括至少有一名11至19岁女孩和/或一名11至14岁男孩的家长（n = 1984）；另一类是法国大陆全科医生的代表性样本。数据通过基于网络的问卷收集，家长和全科医生完成问卷的平均时间为10分钟。采用配额法确保样本的代表性，对于家长样本，依据（i）家庭中的性别、年龄、孩子（11至14岁女孩和/或11至14岁男孩）、“户主”的社会职业类别、城市规模和地区；对于全科医生样本，依据（ii）性别、年龄、地区和执业类型。
尽管大多数全科医生非常支持HPV疫苗接种（94%），但他们认为这是让家长坚持接种的最具挑战性的疫苗之一（82%）。相当比例的家长对HPV疫苗接种持负面看法（25%）。未接种疫苗女孩的家长提到的三个主要障碍是：担心不良反应、信息不足以及全科医生未建议接种。关于将HPV疫苗接种扩展到男孩，84%的全科医生表示如果将其纳入疫苗接种计划，会向男孩推荐这种疫苗；在那些通常不向女孩常规推荐HPV疫苗接种的医生中，88%表示如果建议进行扩展接种，他们更有可能向女孩提供疫苗。
